Home Sectors Healthcare Latest Technicals: Neogen Corporation (NASDAQ: NEOG)

Latest Technicals: Neogen Corporation (NASDAQ: NEOG)


Neogen Corporation trades as part of the medical diagnostics and research industry and is in the healthcare sector. Neogen Corp, through its subsidiaries, develops, manufactures and markets a line of products dedicated to food and animal safety.

Previous Intraday Trading Performance:

The NEOG stock showed a previous change of 0.80% with an open at 61.00 and a close of 61.59. It reached an intraday high of 61.89 and a low of 60.40.

SeekingAlpha:  The Most Expensive Stocks In The Market: May 2019


The stock has a market cap of $3.2b with 52.1m shares outstanding, of which the float is 51.1m shares. Trading volume reached 214,629 shares compared to its average volume of 201,064 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, Neogen Corporation shares returned 8.61% and in the past 30 trading days it returned 2.07%. Over three months, it changed 0.75%. In one year it has changed -21.42% and within that year its 52-week high was 97.38 and its 52-week low was 50.60. NEOG stock is 21.72% above its 52 Week Low.

Our calculations show a 200 day moving average of 64.25 and a 50 day moving average of 58.40. Currently NEOG stock is trading -4.15% below its 200 day moving average and may be a good opportunity to buy, but should check other indicators to confirm a buy signal.

SeekingAlpha:  The Most Expensive Stocks In The Market: May 2019


The last annual fiscal EPS for the company was reported at 1.21 that ended on 31st of May 2018, which according to the previous close, that is a PE of 50.90. Based on 3 analyst estimates, the consensus EPS for the next quarter is 0.28. The TTM EPS is 1.27, which comes to a TTM PE of 48.50. Historically, the PE high was 89.00 and the PE low was 46.50. If the stock reached its PE low, that would represent a price of 59.05, which is a decrease of -4.12%.

Below was the last reported quarterly diluted earnings per share:

Feb19 (Reported on 03/26/2019): 0.25
Nov18 (Reported on 12/20/2018): 0.31
Aug18 (Reported on 09/25/2018): 0.29
May18 (Reported on 07/17/2018): 0.33
Feb18 (Reported on 03/22/2018): 0.32

Base on our calculations, the intrinsic value per share is 25.32, which means it may be overvalued by -143.22%.

Indicators to Watch:

The current calculated beta is 1.35.

SeekingAlpha:  EPA to allow year-round sale of E15 gasoline in bid to help farmers

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 11.00%, return on assets is 10.08%, profit margin is 14.57%, price-to-sales is 10.46 and price-to-book is 5.14.

Company Scores:

All scores are out of six:
 0  :Valuation Score
 2  :Past Performance Score
 6  :Financial Strength Score
 2  :Future Growth Score
 0  :Dividend Score
 2  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.